Prognostic Significance of the Baroreflex Sensitivity Changes After Acute Ischemic Stroke
Noninvasive Study of the Time Course of Baroreflex Sensitivity 6-Month After Acute Ischemic Stroke and the Relation of Its Changes With Post Stroke Prognosis
1 other identifier
observational
100
1 country
1
Brief Summary
After acute stroke, baroreflex sensitivity (BRS) is impaired. This impaired acute stage BRS has been reported to be predictive of worsen outcome years after stroke in general. However, it is not very clear if the impaired acute stroke BRS would actually persist months after the acute stage. It is also not clear that such change, if any, would correlate with the functional outcome or prognosis after stroke. The trial is to investigate the longitudinal time course of BRS after ischemic stroke up to the 6th month post stroke and to see if there is any correlation of the changes in BRS with the functional outcome parameters using NIHSS and mRS scores throughout this period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 14, 2007
CompletedFirst Posted
Study publicly available on registry
January 17, 2007
CompletedJuly 10, 2008
July 1, 2008
January 14, 2007
July 8, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Baroreflex sensitivity can be done within 72 hours of onset of acute ischemic stroke
- years old
- Must have either brain CT or brain MRI done
You may not qualify if:
- NIHSS score \> 10
- Patient could not cooperate
- Unstable vital sign
- Atrial fibrillation
- Transient ischemic attack patient
- Diabetic patient
- Impaired renal function (Cr \> 2.26 mg/dl)
- Unstable angina, acute myocardiac infarction, cardiomyopathy patients
- Patient who has known autonomic dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Far Eastern Memorial Hospital
Banqiao District, Taipei, 220, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Siupak Lee, M.D.
Far Eastern Memorial Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 14, 2007
First Posted
January 17, 2007
Study Start
January 1, 2007
Last Updated
July 10, 2008
Record last verified: 2008-07